Krsnaa Diagnostics reports a strong Q4 & FY26, driven by its integrated diagnostic services and expansion. **Business Performance:** Q4 FY26 revenue grew 4% YoY to ₹192.6 Cr.

Profit after tax (PAT) surged 102% YoY to ₹41.7 Cr, aided by a fair valuation gain.

For the full FY26, revenue increased 8% YoY to ₹772.8 Cr, with PAT up 31% YoY to ₹101.3 Cr.

The company served 4.8 million patients in Q4 FY26 and 19.8 million for the full year, with North India as a key regional contributor. **Growth Drivers:** Strategic expansion in radiology and pathology networks is key.

They aim for 200+ CT/MRI centers, positioning them as a top Asian player, and 5,000+ pathology collection centers through the Rajasthan project, boosting accessibility.

Their focus on affordable diagnostics, high-quality standards, and a robust PPP (Public-Private Partnership) model drives deeper penetration across India. **Recent Developments:** Krsnaa operationalized 51 centers and 1,167 collection centers in FY26. Notably, NABH accredited radiology centers grew 74%. The company also emphasizes AI-enabled diagnostics and a rapidly expanding home collection network across 20+ cities. **Key Financial Metrics:** Q4 FY26 EPS was ₹12.8 (up 103%), and FY26 EPS was ₹30.9 (up 31%). Retail revenue saw significant growth, hitting ₹150.3 Cr in Q4 FY26, leveraging existing PPP infrastructure for superior returns. **Outlook:** Management focuses on expanding market reach across 7-8 new states and building 1,000+ dedicated retail centers.

They continue to drive operational excellence and leverage technology for scalable, affordable diagnostics, reinforcing their commitment to quality and accessibility.